Arterial Line in Trauma Resuscitation (ALTR)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05996068 |
Recruitment Status :
Recruiting
First Posted : August 16, 2023
Last Update Posted : August 16, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Accident-related deaths is the 7th leading cause of death in Taiwan, and most of them is due to trauma from falls and traffic accident. Among trauma patients, the common cause of death is from hemorrhagic shock. Thus, real-time and accurate blood pressure monitoring is important for trauma patients. Incorrect blood pressure monitoring can lead to adverse events like traumatic cardiac arrest and shock and can also delay the time for intervention (fluid resuscitation, blood transfusion and operation). The current practice of blood pressure monitoring in trauma patient is by non-invasive blood pressure monitoring, which may be incorrect and not timely. Patient's body type and peripheral perfusion can both influence the result of non-invasive blood pressure monitoring.
With continuous and correct blood pressure monitoring, the resuscitation team can give adequate and timely treatment. In some trauma centers, arterial line insertion in trauma patients is a daily practice, while the evidence is inadequate and the potential benefit in unknown.
The main purpose of this study is to investigate the application of arterial line insertion in trauma patients. The study design is a prospective before-after study to exam whether arterial line insertion in trauma patients can reduce adverse event rate like hypovolemic shock and improve patient's outcomes.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Major Trauma | Device: arterial line | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 216 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Intervention Model Description: | We use se before-after study type and only the after phase receive intervention. Before phase will retrospectively collect data from patient without arterial line intervention. |
Masking: | None (Open Label) |
Primary Purpose: | Diagnostic |
Official Title: | Enhancing Trauma Resuscitation Through Arterial Line Integration: A Before-After Study |
Actual Study Start Date : | January 1, 2023 |
Estimated Primary Completion Date : | December 31, 2023 |
Estimated Study Completion Date : | December 31, 2023 |
Arm | Intervention/treatment |
---|---|
Active Comparator: trauma patients with arterial line insertion
the after phase, actively recruited patients who are eligible for arterial line insertion
|
Device: arterial line
insert arterial line for patients who meet major trauma criteria |
No Intervention: trauma patients without arterial line insertion
the before phase, retrospectively data collection from the past
|
- composite primary endpoint (including any hypotension, vasopressors usage, any cardiac arrest in ER, Shock index ) [ Time Frame: during ER stay, up to 6 hours ]including any hypotension, vasopressors usage, any cardiac arrest in ER, Shock index (HR/SBP)>1
- prolong ICU admission [ Time Frame: up to 7 days ]define as > 6 days of admission
- 30 days mortality rate [ Time Frame: mortality within 30 days of trauma event ]mortality within 30 days of trauma event
- volume of fluid administration [ Time Frame: during ER stay, up to 6 hours ]any type of fluid administration
- units of red blood cell transfusion [ Time Frame: during ER stay, up to 6 hours ]units of red blood cell transfusion
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Glasgow Coma Scale (GCS) 13 or less
- SBP < 90 mmHg
- Respiratory rate < 10 or > 29 breaths/min
- Fall from height > 6 meters
- High-Risk Auto Crash: Partial or complete ejection, intrusion > 30 cm any site, Need for extrication for entrapped patient, Death in passenger compartment
- Rider separated from transport vehicle with significant impact
- Penetrating injuries to head, neck, torso, and proximal extremities
- Skull deformity, suspected skull fracture
- Chest wall instability, deformity, or suspected flail chest
- Suspected pelvic fracture
- Suspected fracture of two or more proximal long bones
- Amputation proximal to wrist or ankle
- Active bleeding requiring a tourniquet or wound packing with continuous pressure
- Burns in conjunction with trauma
Exclusion Criteria:
- Pregnancy
- Patient or family who are unable to obtain informed consent
- Known coagulopathy that is inappropriate for arterial line insertion
- Known peripheral arterial occlusion disease that is inappropriate for arterial line insertion
- traumatic cardiac arrest
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05996068
Contact: An-fu Lee | +886-5532-3911 ext 563329 | m040608@hotmail.com.tw | |
Contact: Ming-tai Cheng | +886-5532-3911 ext 563329 | jengmt1976@gmail.com |
Taiwan | |
National Taiwan University Hospital Yunlin Branch | Recruiting |
Douliu, Taiwan | |
Contact: An-fu Lee m040608@hotmail.com.tw |
Responsible Party: | National Taiwan University Hospital |
ClinicalTrials.gov Identifier: | NCT05996068 |
Other Study ID Numbers: |
202210095DINC |
First Posted: | August 16, 2023 Key Record Dates |
Last Update Posted: | August 16, 2023 |
Last Verified: | December 2022 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
major trauma arterial line resuscitation |
Wounds and Injuries |